RNA sequencing market - Consumption, Export, Import by Regions, Competitors, Pricing Strategy, Brand Strategy

RNA sequencing or whole transcriptome shotgun sequencing is a process to identify the presence and quantity of RNA present in a biological sample. It enables to analyze the constantly changing cellular transcriptome; identifies gene fusion, post transcriptional modifications, & splicing; and recognizes the exon/intron boundary of the eukaryotic genes.

Advancements of in sequencing technology, increase in acceptance of NGS technology, and growth in number of partnerships & collaborations drive the growth of the global RNA sequencing market. However, dearth of skilled professionals and problems associated with storage of sequencing data restrain the market growth. Government initiatives in population sequencing and emerging markets such as China & India offer significant growth opportunities for the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/2980?utm_source=sy

The market is dominated by players such as

·         Affymetrix Inc.

·         Thermo Fisher Scientific Inc.

·         Agilent Technologies Inc.

·         Bio-Rad Laboratories Inc.

·         GE Healthcare

·         Illumina Inc.

·         Qiagen N.V.

·         F. Hoffmann-La Roche Ltd.

·         Sigma Aldrich

·         Fluidigm Corporation.

The RNA sequencing market in segmented on the basis of products & services, technology, application, end user, and region. Based on products & services, the market is categorized into sample preparation, sequencing platforms & consumables for RNA sequencing; RNA sequencing services; and data analysis, storage, and management. Sample preparation is subsegmented into application and method.

Based on technology, the market is classified into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time (SMRT) sequencing, and nanopore sequencing. Applications covered in the study include de novo transcriptome assembly, expression profiling analysis, variant calling & transcriptome epigenetics, and small RNA sequencing.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/2980?utm_source=sy

According to end user, the market is divided into research centers and academic & government institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others (nonprofit organizations, agrigenomics organizations, and consumer genomics companies). Geographically, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key Benefits

• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of all geographical regions is provided, which helps to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which help to understand competitive outlook of the global market.
• The report offers a quantitative analysis from 2017 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
• Exhaustive analysis of the RNA sequencing market by type helps to understand the types of sequencing technologies that are currently being used along with the variants that are expected to gain prominence in the future.

Access Full Summery @ https://www.alliedmarketresearch.com/rna-sequencing-market?utm_source=sy

Nano Titanium Dioxide Market Report - Growing Technology Trends and Business Opportunities

Nano Titanium Dioxide Market is expected to garner $16,682 million by 2022, registering a CAGR of 20.7% during the period 2016-2022. Consumption of nano titanium dioxide is maximum in cosmetic application throughout the study period. Asia-Pacific is expected to continue to be the leading consumer in the global market until 2022.

Nanoscale titanium dioxide is approximately 100 times finer than the titanium dioxide (TiO2) pigment and is commonly applicable in high-factor sun protection creams, textile fibers or wood preservatives, paints & coatings, and plastics. Factors that drive the nano titanium dioxide market are upsurge in demand for passive protective coatings, growth in penetration of UV-filters in personal care products & sunscreens, and trend towards environmental sustainability. However, toxicity at higher concentration is expected to hamper the market growth along with rise in penetration of nano zinc oxide.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1703?utm_source=sy

Major players in the industry invest significantly in research & development to launch new commercial applications at low cost. Strategic collaborations & business expansion are the other major strategies adopted by some of the industry players.

The major companies profiled in the report include

·         BASF SE

·         Cabot Corporation

·         CINKARNA Celje d.d.

·         Cristal

·         Croda International Plc

·         E. I. Du Pont De Nemours and Company

·         Evonik Industries AG

·         Huntsman International LLC

·         Nano-Oxides Inc.

·         NanoScale Corporation

·         Tayca Corporation.

In 2015, cosmetics was the largest application segment, in terms of revenue and volume, with more than one-third share followed by paints & coatings, pigments, plastics, energy, and others. Furthermore, in cosmetic application nano titanium dioxide is used as UV blocker in various sunscreen applications.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/1703?utm_source=sy

Key Findings of the Nano Titanium Dioxide Market

• Pigment segment is expected to witness highest CAGR of 21.9% during the forecast period.
• Paints & coatings along with cosmetic segment together account for more than two-third market share.
• Asia-Pacific is anticipated to lead the market, growing at a CAGR of 21.3%, in value terms, from 2016 to 2022.
• China, Germany, and U.S. led the global nano titanium dioxide market in 2015.

In 2015, Europe and Asia-Pacific collectively accounted for nearly two-thirds of the worldwide demand for nano titanium dioxide and are expected to maintain their lead position throughout the forecast period. However, Asia-Pacific is projected to be the fastest growing region, with a CAGR of 21.3%, in value terms, followed by LAMEA, North America, and Europe.

Access Full Summery @ https://www.alliedmarketresearch.com/nano-titanium-dioxide-market?utm_source=sy

Biopsy Devices Market - Volume, Value, Sales Price, Specification Forecast

Biopsy Devices Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $2,399 million by 2022, registering a CAGR of 5.5% during the period 2016-2022.

Biopsy devices market isowing to increase in several types of cancer such, as breast, prostate, & lung, and rapid technological advancements in the field of diagnostics. The emerging economies have witnessed an upsurge in the prevalence of chronic diseases due to increase in the aged population and change in lifestyles. The Emergence of novel biopsy techniques and advanced integrated imaging technology, such as MRI, CT, ultrasound scan, and others, are expected to supplement the diagnosis of chronic diseases namely, cancer using biopsy procedures. However, high cost associated with advanced biopsy technologies may restrict the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/1424?utm_source=sy

The key companies profiled in the report are

·         C.R. Bard Inc.

·         Leica Biosystems

·         Hologic Inc.

·         Becton

·         Dickinson and Company

·         Ethicon EndoSurgery Inc.

·         Fujifilm Medical Systems

·         Veran Medical Technologies

·         Boston Scientific Corporation

·         MDxHealth

·         Mauna Kea Technologies

·         Cook Medical Inc.

·         Medtronic

·         Argon Medical Devices Inc

·         Intact Medical Corp.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/1424?utm_source=sy

Key Findings of Biopsy Devices Market:

• CT-guided biopsy segment is anticipated to grow at the highest CAGR of 6.3% during the forecast period.
• The diagnostic centers would continue to lead the revenue generating end use segment by garnering around half of the share in the overall market.
• Lung biopsy is projected to be the fastest growing application segment, registering a CAGR of 7.0%.
• The robotic guidance system segment is expected to register the highest CAGR of 7.0%.
• The Asia-Pacific region is projected to be the fastest growing market, with a CAGR of 7.2%.
• Hospitals are projected be the fastest growing end use segment, owing to increase in integration of diagnostic facilities within the premises.

North America was the highest revenue generating region due to rise in incidences of chronic diseases in 2015. North America and Europe, collectively, accounted for more than three-fourths of the overall market in 2015; this trend is likely to continue over the forecast period. Factors that drive the growth of biopsy devices in the developed regions are awareness about cancer diagnosis, high purchasing power, and availability of skilled personnel to perform biopsy procedures.

Access Full Summery @ https://www.alliedmarketresearch.com/Biopsy-Devices-market?utm_source=sy

Flow Cytometry Market - Gross Margin, Competitors, Business Overview, Distributors Forecast

The Flow Cytometry Market is expected to reach $ 6.5 billion by 2020, growing at an average annual rate of 30.9% between 2020 and 2022, Clinical and diagnostic organizations must adopt innovative technologies as the need to improve precision devices and produce faster results increases and the need for smaller devices increases. Although it has gained popularity in the life sciences industry, the cost of the instrument is hampering growth. Because of this, many researchers are still reluctant to adopt this technology in research technology. In addition, the advanced technology that brought complex instrumentation requires highly skilled individuals to use these instruments.

The flow cytometry market is in the development stage. The increased precision of results and the presence of numerous flow cytometry techniques, such as multicolor and multi-parameter flow cytometry, have provided a strong foothold to support the growth of the majority of developed countries and anticipate high potential in emerging economies. Asia Pacific and Africa. These economies are demanding better health care technology at a reasonable cost. Population growth, which requires an increase in chronic diseases and an increase in patients requiring better diagnosis and treatment, is a major factor influencing the flow cytometry market conditions, AMR analysts Debbie Shields and Rohini Patil.

North America accounted for the largest share of revenue i.e. 43.5% of the overall Global flow cytometry market at $1.2 billion in 2011. The region is further expected to attain a market size of $2.8 billion by 2020 growing at a CAGR of 10.1%.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/90?utm_source=sy

The company profile in this includes:

·         Advanced analytical Technologies Inc.

·         Merck Millipore

·         Becton

·         Dickinson & co

·         Beckman Coulter

·         eBioscience

·         Partech

·         Life technologies corp.

·         Luminex Corp

·         Amnis Corp.

·         Morphosys AG.

The primary strategy employed by key players of the market is products launch, which is due to demand for newer, faster, and higher through put machines that deliver better results.

Immunotyping and signal transduction, for example, have been playing a significant role in medical diagnostics. However, conventional technologies used, have limited the accuracy and impacted the result deliverance time of the diagnosis performed. Improving therapeutic scenario is equally attracting focus on early diagnostic tools. Currently, many cancer types have various treatment options; however, this depends on the time of diagnosis and the stage of the cancer. Flow cytometry has been one of the most prevalent technologies which offer solutions for most of the problems discussed above. Key factors restraining the market include high instrument costs and size, lack of awareness among probable users and need for trained personnel. Most of the users are not aware of the advanced development in the flow cytometry technology and believe that the instruments are space consuming, complex in use and are of high cost, thus affecting the market growth.

Buy Now (Report & Data Pack Available with Discounted Price): @ https://www.alliedmarketresearch.com/checkout/62071?utm_source=sy

The global market for flow cytometry is divided into segments such as products, technology, end users, and applications. Instruments market accounts for the largest share of revenue in the flow cytometry market at present and is expected to remain as the highest revenue generator in 2020. Increase in modularity, accessibility, incorporation of imaging capabilities, availability of wavelengths and targets and size reduction are a few of the significant trends in the market assisting in the adoption of the instruments by the end users. On the other hand, reagents market is expected to experience the highest growth rate of CAGR 12% during the analysis period. A Primary reason escalating this segment is availability of several types of reagents that find diverse usability depending on specific applications like diagnostics, drug discovery, etc.

Two technologies are implemented in flow cytometry based research and diagnosis, namely cell based and bead based technologies. In the present scenario as well as throughout the analysis period, cell based technique is leading the market in terms of revenue generation. However, bead based technique is expected to beat this technology in terms of adoption rate by 2020.

Access Full Summery @ https://www.alliedmarketresearch.com/flow-cytometry-market?utm_source=sy

Global Medical Implant Market - Revenue, Growth Rate, Application, Sales, Trends and Forecast

The Global Medical Implant Market is expected to reach $ 116 billion by 2022. Orthopedic implants are expected to maintain high sales throughout the forecast period. North America led the market in 2015 and is expected to remain dominant over the course of the study.

Key factors driving market growth include technological advances such as bioabsorbable stents, an increased incidence of chronic disease, and an increase in the elderly population worldwide. Improving patient awareness and increasing disposable income in developing countries will further increase the adoption of medical implants. Demand for medical implants is expected to increase with the emergence of emerging market market opportunities and minimally invasive surgical procedures. Alternatively, high-cost medical implants and limited coverage are key factors that impede market growth.

The major strategies adopted by the leading market players include new product launches & approvals and collaborations. In March, 2016, Zimmer Biomet launched the hip replacement offering and knee implant systems. It enhanced the companys implant and musculoskeletal treatment product portfolio and helped to strengthen their existing product portfolio.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/71?utm_source=sy

The major companies profiled in this report include

·         Stryker Corporation

·         Boston Scientific Corporation

·         Johnson & Johnson

·         Integra Lifesciences Holdings Corporation

·         Medtronic Plc.

·         Smith & Nephew Plc.

·         St. Jude Medical Inc.

·         Zimmer Biomet Holdings Inc.

·         C.R. Bard Inc.

·         LivaNova Plc.

·         Straumann AG.

These devices are further categorized into reconstructive joint replacements, orthobiologics, and trauma & craniomaxillofacial, among which reconstructive joint replacements had the highest market share in 2015.

Neurostimulators has emerged as the fastest growing segment, registering a CAGR of 12.7% during the forecast period. The major factors contributing to this segments growth are increasing prevalence of neurological disorders, high adoption rate in developed economies, and increasing number of clinical trials. The metallic segment was the leading biomaterial, due to its increasing usage as load bearing implants in joint reconstruction surgeries and dental implants, in 2015.

Buy Now (Report & Data Pack Available with Discounted Price): @ https://www.alliedmarketresearch.com/checkout/953538?utm_source=sy

Key findings of Medical Implants Market:

• Orthopaedic implant generated the highest revenue in 2015, and is projected to grow at a CAGR of 7.2% during the forecast period.
• The neurostimulators segment is expected to grow at a remarkable CAGR of 12.7% during the analysis period.
• U.S. is the major shareholder accounting for 70.7% share of the overall North American medical implants market.
• Dental implants market is projected to grow at a CAGR of 8.2%.
• Germany accounted for around one-fourth share of the European medical implants market in 2015.
• Japan medical implants market is expected to continue to be the highest revenue-generating market in Asia-Pacific.

Geographically, the North American region accounted for the majority of the share in the medical implant market in 2015, and is expected to maintain its lead throughout the forecast period. This is attributed to the high awareness and the advance healthcare infrastructure in this region. However, Asia-Pacific is projected to be the fastest growing region due to the increasing incidence of chronic disorders (such as heart disease, cancer, and diabetes), growing geriatric population, and improving health care infrastructure.

The medical implants market in Germany is growing at a steady pace, attributed to the rising incidence of chronic diseases. Germany has one of the highest death rates due to heart diseases (even higher than the U.S. or U.K.), lifestyle factors such as increase in rate of smoking (In Germany, for group of more than 15 years of age population, on an average nearly 24.5% are smokers, in the age group 18 to 25 years 35.2% are smokers) and rise in obesity are the major factors behind the health diseases. The country spends more on dental services compared to any other European country apart from Switzerland, which makes it an attractive market for the dental implants industry.

Access Full Summery @ https://www.alliedmarketresearch.com/medical-implants-market?utm_source=sy

Capnography Market Anticipated to Grow at an Impressive Rate during the Period

Capnography is a medical device that monitors the concentration or partial pressure of carbon dioxide excreted or present in the bloodstream. It is majorly used to monitor CO2 during anesthesia and intensive care. It also helps diagnose the cause of respiratory distress, provide real-time feedback on treatment effects, and detect shock.

Growth in the prevalence of respiratory diseases, increasing surgeries, and a rise in geriatric population drive the growth of the capnography market. Furthermore, extended utility of capnography in emergency rooms, endoscopic suites, onsite emergency, trauma fields, and X-ray rooms have fuelled the growth of the market. A rise in disposable income and increase in investments in healthcare by governments & private organizations are anticipated to propel the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/3944?utm_source=sy

List of players profiled in the report

• Medtronic Plc.
• Becton, Dickinson and Company
• Getinge AB
• Beijing Aeonmed Co., Ltd.
• Drgerwerk AG
• General Electric Company
• Hamilton Medical AG
• Maxtec, Inc.
• SLE Limited
• Koninklijke Philips N.V.

However, lack of skilled professionals, no or less product differentiation among the brands, and stringent government regulations related to the safety & efficacy of capnography hinder the market growth. Ongoing R&D activities related to capnography are anticipated to present new opportunities for the market.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/3944?utm_source=sy

The market is segmented on the basis of product, application, end-user, and geography. Based on product, the market is categorized into capnographs and capnography disposables. By application, it is categorized into procedural sedation, pain management, emergency medicine, critical care, general floor, and others. By end-user, it is segmented into hospitals and ambulatory. The geographical breakdown of each of the aforesaid segments has been covered for North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

• The study provides an in-depth analysis of the global capnography market with current trends and future estimations to elucidate investment pockets.
• Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
• The report provides a quantitative analysis from 20172023, which enables stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of different segments helps understand various products of the market.
• Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

Access Full Summery @ https://www.alliedmarketresearch.com/capnography-market?utm_source=sy